Novocure Reports 2015 Operating Statistics and Financial Results

Year ended December 31, ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR), a commercial stage oncology company pioneering a novel therapy for solid tumors, reported today 2015 operating statistics and financial results, highlighting strong growth in both prescriptions and active patients driven primarily by the October 2015 U.S. Food and Drug Administration (FDA) approval of Optune for …

Novocure to Present at Cowen and Company 36th Annual Health Care Conference

ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure will present at Cowen and Company 36th Annual Health Care Conference on March 7, 2016, in Boston. William Doyle, Novocure’s Executive Chairman, will speak on behalf of the company and address questions from analysts. Mr. Doyle’s presentation will begin at 1:20 p.m. EST and will be followed by a Q&A session. …

Anthem Inc. Issues Positive Coverage Decision For Optune in Newly Diagnosed Glioblastoma

Health insurance plans covering more than 97 million Americans now provide positive coverage of Optune ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ:NVCR) announced today that Anthem, Inc. now covers Optune for members who have newly diagnosed glioblastoma (GBM). Anthem, the largest member of the Blue Cross Blue Shield Association, is one of the nation’s leading health benefits …

Novocure’s Phase 3 Pivotal Trial Results in Newly Diagnosed Glioblastoma Selected For ASCO’s Clinical Cancer Advances 2016 Report

ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure’s (NASDAQ: NVCR) phase 3 pivotal clinical trial results of Tumor Treating Fields (TTFields) in combination with temozolomide in newly diagnosed glioblastoma (GBM) have been selected for inclusion in the American Society of Clinical Oncology’s Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer. The report, which was published first online …

Novocure to Report Fourth Quarter, Year-End Financial Results

ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) will hold a conference call and webcast to discuss its fourth quarter and full-year 2015 financial results at 5 p.m. EST on Feb. 29, 2016. Schedule for press release and conference call: Q4 and year-end press release: After market close on Feb. 29, 2016 Q4 and year-end conference call/webcast: 5 …